Welcome!
The main purpose of Radiopharmacy core facility (RCF) is to promote the use and development of PET tracers in translational research from preclinical to clinical applications as well as within routine nuclear medicine diagnostics.
The major focus for RCF is radiochemistry development and production of radiotracers which can be broadly applied for imaging research in psychiatry, neurodegeneration, oncology, inflammation, cardiovascular disease etc.
A combined core facility, RCF, by KI and SLL is essential for the supply of existing and development of novel PET tracers for preclinical and clinical PET studies within all applications for both academia and for pharmaceutical industry sponsored studies.
| Working Hours: | |
|
Monday - Friday
|
8:00 - 17:00h |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Thuy Tran |
RCF Manager: Region Stockholm
|
072 7418988
|
thuy.tran@ki.se
|
|
| Guennadi Jogolev |
RCF Manager: Karolinska Institutet
|
070 720 41 02
|
guennadi.jogolev@ki.se
|
|
| Erik Samén |
Director
|
072 581 58 28
|
erik.samen@sll.se
|
|
| Christer Haldin |
Scientific director
|
070 484 49 89
|
christer.halldin@ki.se
|
